Regencell Bioscience Holdings Limited Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited

RGC

Kedudukan dalam Saham #3437
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Harga Saham
$10.10
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$5.01B
Perubahan (1 hari)
5.32%
Perubahan (1 tahun)
-40.45%
Negara
HK
Perdagangan Regencell Bioscience Holdings Limited (RGC)

Kategori

Healthcare
Sejarah dividen untuk Regencell Bioscience Holdings Limited (RGC)
Regencell Bioscience Holdings Limited (simbol saham: RGC) telah membuat sejumlah 36 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): $7.52
Hasil dividen (TTM): 0
Pembayaran dividen untuk Regencell Bioscience Holdings Limited (RGC) dari 2009 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (diselaraskan untuk pemecahan saham) Ubah
2026 (TTM) $0.22 0.00%
2018 $0.22 -75.00%
2017 $0.88 0.00%
2016 $0.88 0.00%
2015 $0.88 0.00%
2014 $0.88 4.76%
2013 $0.84 0.00%
2012 $0.84 0.00%
2011 $0.84 16.67%
2010 $0.72 33.33%
2009 $0.54 0.00%
Senarai semua pembayaran dividen
Tahun Dividen Ubah
2026 (TTM) $8.36 0.00%
2018 $8.36 -75.00%
2017 $33.44 0.00%
2016 $33.44 0.00%
2015 $33.44 0.00%
2014 $33.44 4.76%
2013 $31.92 0.00%
2012 $31.92 0.00%
2011 $31.92 16.67%
2010 $27.36 33.33%
2009 $20.52 0.00%
Pembayaran dividen untuk syarikat serupa atau pesaing